Industry analysts expect M&A activity in the biotech space to accelerate in the back half of 2021 – and that could drive the ETF highlighted… Read More »This Biotech ETF Is “Prime Hunting Ground” For Big Pharma Companies Looking For Takeover Targets
After a down year for M&A activity in the biotech industry, 2021 is expected to see greater deal volume – and the four biotechs highlighted… Read More »Bought Out Or Standalone, These 4 Potential Biotech Takeover Targets Are Attractive Picks
Low-priced stocks offer smaller investors the chance to not only make a tidy profit (as these stocks can provide the largest short-term gains), but also… Read More »5 Low-Priced Biotech Stocks For Big Share Counts – And Big Potential Gains
Low-priced stocks offer investors – especially more aggressive traders – the opportunity to not only make a decent profit in the event of even relatively… Read More »5 Stocks With Low Prices And Big Potential